32P-postlabelling with high-performance liquid chromatography for analysis of abundant DNA adducts in human tissues.
Abundant complex DNA adducts can be detected in human tissues by a combined 32P-postlabelling and high-performance liquid chromatography (HPLC) method. The HPLC profiles reveal a panorama of nuclease P1-resistant human adducts, which are not among the known human DNA adducts and are suspected of being endogenous. Lipid peroxidation-induced DNA adducts and I-compounds are two possible candidates for these adducts. Therefore, we performed two experiments: one was to identify chromatographically the lipid peroxidation-induced adducts among other human adducts with two acrolein- and crotonaldehyde-derived propano adduct standards (Acr-dG3 and Cro-dG1&2) and a structurally unknown adduct (Cro-DNA) derived from crotonaldehyde-treated DNA; and the other was to analyse the adducts in breast tissue from patients with breast cancer and from controls and to compare their behaviour with that of I-compounds in cancerous tissues. In the first experiment, Acr-dG3 and Cro-dG1 were detected in three human lung tissues, at levels ranging from 3.4 to 8.9 (x 10(-8)) and from not detectable to 2.9 (x 10(-8)), respectively. Acr-dG3 and Cro-DNA were detected in three human colon tissues, at levels of 0.2-0.4 (x 10(-8)) and 1.2-3.4 (x 10(-8)), respectively. In the second experiment, adjacent and tumorous breast tissues from 15 patients with breast cancer (of an average age of 33.4 years) and normal breast tissue from 18 controls (of an average age of 57.3) were analysed for the abundant complex adducts. The total adduct levels in the adjacent and tumorous tissues were lower than in the normal tissues (with medians of 8.0, 11.8 and 13.3 (x 10(-7)), respectively). Significant differences in the adduct levels between adjacent or tumorous tissues and normal tissues were observed in three HPLC peaks, and age was significantly associated with three peaks. These results are consistent with our speculation that the abundant adducts are comprised of lipid peroxidation-induced adducts and human homologues of I-compounds.
Yang
K
K
Molecular Epidemiology Unit, CNT, Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden.
Fang
J L
JL
Li
D
D
Chung
F L
FL
Hemminki
K
K
D000171:Acrolein / Q000032:analysis; D000328:Adult; D000367:Age Factors; D000368:Aged; D000447:Aldehydes / Q000032:analysis; D000818:Animals; D001940:Breast / Q000378:metabolism; D001943:Breast Neoplasms / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003106:Colon / Q000378:metabolism; D018736:DNA Adducts / Q000032:analysis*; D005260:Female; D006801:Humans; D008168:Lung / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010761:Phosphorus Radioisotopes / Q000378:metabolism; D051381:Rats; D014018:Tissue Distribution
D000447:Aldehydes; D018736:DNA Adducts; D010761:Phosphorus Radioisotopes; D000171:Acrolein; C012796:2-butenal